These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25825015)

  • 1. Mefloquine at the crossroads? Implications for malaria chemoprophylaxis in Europe.
    Schlagenhauf P; Hatz C; Behrens R; Visser L; Funk M; Holzer B; Beck B; Bourquin C; Etter H; Furrer H; Genton B; Landry P; Chappuis F; Loutan L; Stössel U; Jeschko E; Rossanese A; Nothdurft HD
    Travel Med Infect Dis; 2015; 13(2):192-6. PubMed ID: 25825015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The position of mefloquine as a 21st century malaria chemoprophylaxis.
    Schlagenhauf P; Adamcova M; Regep L; Schaerer MT; Rhein HG
    Malar J; 2010 Dec; 9():357. PubMed ID: 21143906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations.
    Shellvarajah M; Hatz C; Schlagenhauf P
    Travel Med Infect Dis; 2017 Sep; 19():49-55. PubMed ID: 28939502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
    Adamcova M; Schaerer MT; Bercaru I; Cockburn I; Rhein HG; Schlagenhauf P
    Travel Med Infect Dis; 2015; 13(5):400-8. PubMed ID: 26119539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa.
    Widmer LL; Blank PR; Van Herck K; Hatz C; Schlagenhauf P
    BMC Infect Dis; 2010 Sep; 10():279. PubMed ID: 20860809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis of malaria].
    Gentilini M; Caumes E; Danis M
    Rev Med Interne; 1992; 13(3):233-7. PubMed ID: 1410907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine to prevent malaria: a systematic review of trials.
    Croft A; Garner P
    BMJ; 1997 Nov; 315(7120):1412-6. PubMed ID: 9418088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment and prevention of malaria among Italian troops in Afghanistan, 2002 to 2011.
    Peragallo MS; Sarnicola G; Boccolini D; Romi R; Mammana G
    J Travel Med; 2014; 21(1):24-32. PubMed ID: 24383651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis.
    Islam N; Wright S; Lau CL; Doi SAR; Mills DJ; Clark J; Clements ACA; Furuya-Kanamori L
    J Travel Med; 2021 Jul; 28(5):. PubMed ID: 33834208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
    Matsumura T; Fujii T; Miura T; Koibuchi T; Endo T; Nakamura H; Odawara T; Iwamoto A; Nakamura T
    J Infect Chemother; 2005 Aug; 11(4):196-8. PubMed ID: 16133712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and misconceptions in malaria chemoprophylaxis for travelers.
    Chen LH; Wilson ME; Schlagenhauf P
    JAMA; 2007 May; 297(20):2251-63. PubMed ID: 17519415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadequate chemoprophylaxis and the risk of malaria.
    Massey P; Durrheim DN; Speare R
    Aust Fam Physician; 2007 Dec; 36(12):1058-60. PubMed ID: 18075636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique.
    Gobbi F; Rossanese A; Buonfrate D; Angheben A; Lunardi G; Bisoffi Z
    Malar J; 2013 Dec; 12():451. PubMed ID: 24350652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian army standpoint on malaria chemoprophylaxis.
    Peragallo MS
    Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data.
    Schlagenhauf P; Adamcova M; Regep L; Schaerer MT; Bansod S; Rhein HG
    Malar J; 2011 Oct; 10():292. PubMed ID: 21981927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
    Mizuno Y; Kudo K; Kano S
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.